These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30597153)

  • 1. Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features.
    Hatano M; Ojima H; Masugi Y; Tsujikawa H; Hiraoka N; Kanai Y; Shimada K; Shinoda M; Sakamoto M
    Hum Pathol; 2019 Apr; 86():222-232. PubMed ID: 30597153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
    Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
    Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological study of scirrhous hepatocellular carcinoma.
    Kurogi M; Nakashima O; Miyaaki H; Fujimoto M; Kojiro M
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1470-7. PubMed ID: 16911695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
    Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
    Chan AW; Yu S; Yu YH; Tong JH; Wang L; Tin EK; Chong CC; Chan SL; Wong GL; Wong VW; Chan HL; Lai PB; To KF
    Histopathology; 2016 Dec; 69(6):971-984. PubMed ID: 27380543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin.
    Kubota N; Ojima H; Hatano M; Yamazaki K; Masugi Y; Tsujikawa H; Fujii-Nishimura Y; Ueno A; Kurebayashi Y; Shinoda M; Kitago M; Abe Y; Kitagawa Y; Sakamoto M
    Pathol Int; 2020 Apr; 70(4):199-209. PubMed ID: 31930673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.
    Morisue R; Kojima M; Suzuki T; Nakatsura T; Ojima H; Watanabe R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Ishii G; Gotohda N; Fujiwara T; Ochiai A
    Int J Cancer; 2021 Aug; 149(3):546-560. PubMed ID: 33662146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.
    Coulouarn C; Cavard C; Rubbia-Brandt L; Audebourg A; Dumont F; Jacques S; Just PA; Clément B; Gilgenkrantz H; Perret C; Terris B
    Carcinogenesis; 2012 Sep; 33(9):1791-6. PubMed ID: 22696594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liver: Clinical and pathological features.
    Shigematsu Y; Kanda H; Amori G; Takahashi Y; Takazawa Y; Inamura K
    Medicine (Baltimore); 2022 Feb; 101(5):e28746. PubMed ID: 35119029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1.
    Matsuura S; Aishima S; Taguchi K; Asayama Y; Terashi T; Honda H; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):382-90. PubMed ID: 16178893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
    Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC.
    Chen S; Liao C; Hu H; Liao J; Chen Z; Li S; Zeng X; Peng B; Shen S; Li D; Li S; Lai J; Peng S; Xie Y; Kuang M
    Hepatology; 2024 Apr; 79(4):780-797. PubMed ID: 37725755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
    Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
    World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
    J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatotic and Steatohepatitic Hepatocellular Carcinomas: Features in a Series With Predominantly Viral Etiology.
    Aykutlu U; Argon A; Orman M; Ulukaya S; Zeytunlu M; Karasu Z; Günşar F; Nart D; Akarca U; Yilmaz F
    Am J Surg Pathol; 2021 Sep; 45(9):1252-1263. PubMed ID: 33826548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics of Wnt/β-catenin-deregulated hepatocellular carcinoma.
    Verma A; Bal M; Ramadwar M; Deodhar K; Patil P; Goel M
    Indian J Cancer; 2017; 54(4):634-639. PubMed ID: 30082549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four immunohistochemically different primary liver cancers in one patient.
    Ariizumi S; Takasaki K; Otsubo T; Yamamoto M; Nakano M
    J Gastroenterol; 2002; 37(9):750-4. PubMed ID: 12375151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma.
    Ding X; Yang LY; Huang GW; Wang W; Lu WQ
    World J Gastroenterol; 2004 Sep; 10(18):2735-9. PubMed ID: 15309730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.